AstraZeneca
| Institution is active | |
| Founding date | 06.04.1999 |
| Headquarters | Cambridge, UK |
| Website | http://www.astrazeneca.com/ |
Connections
AstraZeneca
- Partner of WEF -
World Economic Forum
No information yet.
AstraZeneca
- AstraZeneca interested in fusion with Gilead Sciences -
Gilead Sciences
In early June 2020, it was reported that AstraZeneca was interested in a merger with Gilead Sciences.
WiKipedia [* muss spezifiziert werden *]
AstraZeneca
- Treaty over 300 million vaccine doses -
Deutschland (Staat)
No information yet.
AstraZeneca
-
BARDA
No information yet.
AstraZeneca
-
USA (Staat)
On May 21, 2020, it was announced that the U.S. government had pre-ordered 300 million doses of the COVID-19 vaccine being developed by AstraZeneca.
In addition, the U.S. is investing up to $1.2 billion in the development of this COVID-19 vaccine from the British pharmaceutical company AstraZeneca.
In addition, the U.S. is investing up to $1.2 billion in the development of this COVID-19 vaccine from the British pharmaceutical company AstraZeneca.
WiKipedia [* muss spezifiziert werden *]
AstraZeneca
-
Moderna
No information yet.
AstraZeneca
-
Serum Institute of India
The Serum Institute of India (SII) and Astrazeneca have made a license agreement to deliver a billion doses by the University of Oxford's vaccine candidate against Covid-19 to countries with medium and low incomes, including India. By the end of 2020, both companies have undertaken to provide 400 million cans, said Astraza in a statement on June 4th, 2020.
Press release from AstraZeneca
https://www.astranceca.com/media-centre/press-releases/2020/astrzenceca-takes-next-tovs-towards-and- and
Press release from AstraZeneca
https://www.astranceca.com/media-centre/press-releases/2020/astrzenceca-takes-next-tovs-towards-and- and
AstraZeneca
- Supplier -
Edelman
No information yet.
AstraZeneca
- founded -
Syngenta Group
At the end of the 1990s, the fusion of Astra and Zeneca was the third largest chemical and pharmaceutical manufacturers worldwide. In 2000, Astrazeneca and Novartis decided to integrate their business with seeds and pesticides. The Syngenta joint venture was created from this. The joint venture was headquartered in Basel and was introduced on the market on the stock exchanges in London, New York, Stockholm and Zurich.
AstraZeneca
- participation -
Soros Fund Management
Astrazeneca PLC is a global pharmaceutical company in which Soros Fund Management is involved.
WiKipedia [* muss spezifiziert werden *]